Jiangxi Black Cat Carbon Black (002068.SZ) stock: key figures, P/E, revenue and dividend
Materials · Commodity Chemicals · China · ISIN CNE000001NQ3
Jiangxi Black Cat Carbon Black financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 10.13 bn CNY | 8.69 bn CNY |
| Gross profit | 470.57 m CNY | 142.12 m CNY |
| Operating income | 43.58 m CNY | -248.79 m CNY |
| EBIT | 142.51 m CNY | -395.72 m CNY |
| Net income | 25.13 m CNY | -463.34 m CNY |
| Diluted EPS – continuing operations | 0.03 CNY | -0.63 CNY |
Full history since 2003, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Jiangxi Black Cat Carbon Black
Jiangxi Black Cat Carbon Black Inc.,Ltd, together with its subsidiaries, manufactures and sells carbon black products in China. It operates through Carbon Black, Tar Refining, and Other segments. The company offers carbon black for rubber, special carbon black, green carbon black, precipitated and fumed silica, and chemical products; and tar refining and white carbon black products. It is also involved in power generation, transmission, distribution, and supply; energy conservation and environmental protection consultation, renovation, and installation; research, development, production, testing, and consulting on carbon composites and nanomaterials; and carbon black exhaust gas waste heat power generation. In addition, the company offers carbon black oil; chemical raw materials; hazardous chemicals; consulting services; graphite products; pigments; batteries; fiber, composite, and synthetic materials; and rubber products. It exports its products. The company was founded in 1994 and is headquartered in Jingdezhen, China.
More stocks
- R&G PharmaStudies Co. Ltd. A (301333.SZ)
- Jaya Real Property Tbk (JRPT.JK)
- Ottogi (007310.KS)
- GFT Technologies (GFT.DE)
- Kuros Biosciences AG (KURN.SW)
- Basler (BSL.DE)
- Guangdong Hongjing Optoelectronic Technology Inc. (301479.SZ)
- Chengdu Bright Eye Hospital Co. Ltd. (301239.SZ)
- Chongqing Road & Bridge Co Ltd (600106.SS)
- Knight Therapeutics Inc (GUD.TO)
- Evolv Technologies Holdings, Inc. (EVLV)
- Chongqing Pharscin Pharmaceutical Co Ltd (002907.SZ)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.